Many life-threatening bacteria are becoming increasingly resistant to existing antibiotics. Swiss researchers co-headed by the University of Zurich have now discovered a new class of antibiotics with a unique spectrum of activity and mechanism of action – a major step in the fight against a ... more
Dr. Steven A. Brown
Universität Zürich, Institut für Pharmakologie und Toxikologie
Steven B. Brown studied biochemistry at Harvard College, Cambridge, Massachusetts, USA. In 1997 he received his doctorate in the Department of Biological Chemistry and Molecular Pharmacology, Harvard University, Cambridge, Massachusetts, USA. From 1998 – 2005 he was a postdoctoral fellow at the Institute of Molecular Biology at the University of Geneva in the laboratory of Prof. Ueli Schibler, and began his active work on circadian rhythms (Research Project: The identification of proteins and signalling mechanisms involved in the regulation of mammalian circadian rhythms). In 2006, as a Humboldt Fellow at the Charité in Berlin (Prof. Achim Kramer), he researched the topic “Molecular mechanisms regulating chronotype”. Since September 2006 he is Professor of Pharmacology and Toxicology at the Medical Faculty of the University of Zurich.